DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME

The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the ho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PARK IN SOOK, PARK MI JU, LEE YOUNG AE, OH SEON HWAN, KIM DO YUN, YOO JIN SAN, LEE SANG HOON, CHOI JIN HEE, LEE JIN SOOK, YOON JAE BONG, KIM SUNG WOO, JEONG JONG GEUN, JEONG BO YOUNG, KIM NAM YE, LEE SEON YOUNG, KIM YEUN JU, NAHM KYUNG HEE, LEE WEON SUP, KIM JOONG KYU, SHIM SANG RYEOL, NAM JU RYUNG, LEE HYUK JOON, YOO JIN SANG, BYUN SANG SOON, LEE EUN JIN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.